Therapeutic deep eutectic systems (THEDESs) represent an approach for modulating drug physicochemical properties without structural modifications of the active pharmaceutical ingredient. In this study, novel THEDESs based on fentanyl (FEN) and fatty acids lauric acid (LA) and capric acid (CA) are reported for the first time. Both FEN:LA and FEN:CA systems were initially prepared. Phase diagram analysis confirmed eutectic formation at equimolar compositions, accompanied by melting-point depression (18 °C for FEN:LA and ~10.5 °C for FEN:CA). Rheological analysis revealed sharp viscosity decreases at eutectic compositions, with FEN:CA exhibiting consistently lower viscosity than FEN:LA. Therefore, full characterization was subsequently pursued only for the eutectic FEN:CA composition. The system was characterized using Attenuated Total Reflectance–Fourier Transform Infrared (ATR–FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), Polarized Optical Microscopy (POM), solubility, ex-vivo skin permeation, Physiologically Based Pharmacokinetic Modeling (PBPM) and Molecular Dynamics Simulations (MDS). ATR–FTIR spectra revealed band shifts and broadening, consistent with hydrogen-bond formation between the carboxyl group of CA and the amino group of FEN. DSC thermograms showed the disappearance of individual component melting transitions and the emergence of a single depressed endothermic event, confirming eutectic phase formation. POM revealed rapid co-melting and crystal disappearance at room temperature. Solubility study revealed exceptional enhancement in FEN solubility (>65,000-fold relative to water). Ex-vivo skin permeation studies demonstrated that melting-point depression critically governs transdermal performance. PBPK simulations indicated that systemic exposure remained dose limited. MDS indicated stronger interactions in the FEN–CA system compared to FEN-LA.